Actualités réglementaires
18 sept. 2026•1 min de lecture
FDA Grants ANDA Approval for Atomoxetine Capsules by Strides Pharma
The FDA approved ANDA 079021 for atomoxetine hydrochloride capsules from Strides Pharma Science, covering strengths from 10 mg to 100 mg.
1
Actualités réglementaires
17 sept. 2026•1 min de lecture
FDA Approves Minocycline Hydrochloride Tablets (ANDA 065131)
The FDA approved Strides Pharma's minocycline hydrochloride oral tablets (50 mg, 75 mg, 100 mg) under ANDA 065131, confirming prescription status.
Actualités réglementaires
30 août 2026•1 min de lecture
FDA Approves Imipramine Hydrochloride (ANDA088292)
FDA grants approval for ANDA088292, an oral imipramine hydrochloride tablet by Strides Pharma Science Limited, with details on dosage, NDC codes, and submission history.